APW
CRVO icon

Aventura Private Wealth’s CervoMed CRVO Stock Holding History

Aventura Private Wealth’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-68
Closed -$550 – 873
2025
Q3 		$550 Hold
68
– – ﹤0.01% 759
2025
Q2 		$427 Hold
68
– – ﹤0.01% 732
2025
Q1 		$622 Hold
68
– – ﹤0.01% 700
2024
Q4 		$159 Buy
+68
New +$661 ﹤0.01% 733

Other funds holding CRVO

AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $6.36B AUM 28.76% 1-Year Est. Return

Aventura Private Wealth's CRVO Position: Q4 2025 in Review

Aventura Private Wealth sold out of CervoMed (CRVO) in Q4 2025, closing a stake of 68 shares — an estimated $550 sold.

Aventura Private Wealth first reported a position in CRVO in Q4 2024 and held it in 4 quarters. The position peaked at $622 in Q1 2025. 48 funds tracked by Wall St. Rank hold CRVO as of Q4 2025.

  • Aventura Private Wealth reported no remaining CervoMed position as of Q4 2025 after selling out during the quarter.
  • Aventura Private Wealth sold 68 CervoMed shares in Q4 2025, an estimated $550.
  • Aventura Private Wealth first reported a position in CervoMed in Q4 2024 and held it in 4 quarters.
  • Aventura Private Wealth's CervoMed position peaked at $622 in Q1 2025.
  • 48 funds tracked by Wall St. Rank held CervoMed as of Q4 2025.

Based on Aventura Private Wealth's 13F filing for Q4 2025, filed 7 Jan 2026.